You are here: Industry Insights > COVID-19

News List

Zenara Pharma, a Biophore subsidiary, gets DCGI nod for favipiravir tablets expresspharma
August 06, 2020
The company informed that these tablets, to be marketed under brand name Favizen, will be manufactured with in-house API.
Lupin launches generic favipiravir, Covihalt to treat coronavirus infection expresspharma
August 06, 2020
Lupin’s Covihalt is available as 200 mg tablets in the form of a strip of 10 tablets and priced at Rs 49 per tablet.
AbCellera provides Covid-19 programme update with start of phase 3 clinical trials pharmaceutical-business-review
August 05, 2020
AbCellera announced that LY-CoV555, a human antibody discovered by AbCellera in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID) Vaccine Research Center (VRC) and co-developed with Eli Lilly and Company (Lilly) as ...
NHS adapts to pandemic with ‘COVID-friendly’ cancer treatments pharmatimes
August 05, 2020
NHS chief executive Sir Simon Stevens has announced plans for a ￡160m initiative to roll-out ‘COVID-friendly’ cancer treatments for patients across the UK.
Pharma’s reputation has climbed during COVID-19 pandemic, study finds pharmatimes
August 05, 2020
A study from FutureBrand found that the perception of pharma and healthcare companies improved since the beginning of the COVID-19 pandemic.
Truvian Receives FDA Emergency Use Authorization for COVID-19 IgM/IgG Test americanpharmaceuticalreview
August 05, 2020
Truvian Sciences announced the U.S. Food and Drug Administration (FDA) issued Emergency Use Authorization (EUA) for the company's Easy Check COVID-19 IgM/IgGTM antibody test.
Partner Therapeutics Wins $35M DoD Contract for Leukine in COVID-19 contractpharma
August 05, 2020
Funding will support two clinical trials in COVID-19 patients, expansion of manufacturing capacity and potential Emergency Use Authorization filing.
Beroni Group Provides Update on COVID-19 Nanobody Tech contractpharma
August 05, 2020
Has successfully constructed & purified 24 types of nanobodies for detection & treatment of COVID-19.
Sun Pharma launches generic favipiravir, FluGuard at Rs 35 per tablet expresspharma
August 05, 2020
Sun Pharmaceutical Industries has launched FluGuard (Favipiravir 200 mg) at a price of Rs 35 per tablet, for the treatment of mild to moderate cases of COVID-19 in India.
Maha FDA seizes 15 vials of tocilizumab black marketed at Rs one lakh each expresspharma
August 05, 2020
The Maharashtra Food and Drug Administration (FDA) has seized 15 vials of tocilizumab from a non-authorised license holder in Bandra, Mumbai. The team has arrested and filed an FIR against him.